Six minute walk test in type III spinal muscular atrophy: A 12month longitudinal study

Neuromuscular Disorders

Volumn 23, Issue 8, 2013, Pages 624-628

  Mazzone, E ^a   Bianco, F ^a   Main, M ^b   van den Hauwe, M ^c   Ash, M ^b   de Vries, R ^d   Fagoaga Mata, J ^e   Stein, S ^f   De Sanctis, R ^a   D'Amico, A ^g   Palermo, C ^a   Fanelli, L ^a   Scoto, M C ^b   Mayhew, A ^h   Eagle, M ^h   Vigo, M ^e   Febrer, A ^e   Korinthenberg, R ^f   de Visser, M ^d   Bushby, K ^h   Muntoni, F ^b   Goemans, N ^c   Sormani, M P ⁱ   Bertini, E ^g   Pane, M ^a   Mercuri, E ^a   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e U Integr Hosp St Joan Deu Clinic   (Spain)

^f UNIVERSITY OF FREIBURG   (Germany)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY OF GENOA   (Italy)

Author keywords

6MWT; Outcome measures; Spinal muscular atrophy

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FUNCTION TEST; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SIX MINUTE WALK TEST; SPINAL MUSCULAR ATROPHY; WALKING SPEED;

6MWT; OUTCOME MEASURES; SPINAL MUSCULAR ATROPHY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ATROPHY; CHILD; CHILD, PRESCHOOL; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; WALKING; YOUNG ADULT;

EID: 84880947911     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.06.001     Document Type: Article

References (11)

1. Bertini E., Burghes A., Bushby K., et al. 134th ENMC international workshop: outcome measures and treatment of spinal muscular atrophy, 11-13 February 2005, Naarden, The Netherlands. Neuromuscul Disord 2005, 15:802-816.
2. Mercuri E., Mayhew A., Muntoni F., et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint institute of myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008, 18:894-903.
3. Montes J., Gordon A.M., Pandya S., De Vivo D.C., Kaufmann P. Clinical outcome measures in spinal muscular atrophy. J Child Neurol 2009, 24:968-978.
4. Montes J., McDermott M.P., Martens W.B., et al. Six-minute walk test demonstrates motor fatigue in spinal muscular atrophy. Neurology 2010, 74:833-838.
5. Mazzone E., Vasco G., Sormani M.P., et al. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology 2011, 77:250-256.
6. Wokke J.H., Escolar D.M., Pestronk A., et al. Clinical features of late-onset pompe disease: a prospective cohort study. Muscle Nerve 2008, 38:1236-1245.
7. Takeuchi Y., Katsuno M., Banno H., et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008, 38:964-971.
8. ATS statement Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
9. Tiziano F.D., Lomastro R., Di Pietro L., et al. Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study. Eur J Hum Genet 2013, 21:630-636.
10. Wadman R.I., Vrancken A.F., van den Berg L.H., van der Pol W.L. Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3. Neurology 2012, 79:2050-2055.
11. Henricson E., Abresch R., Han J.J., et al. Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences. PLoS Curr 2012, 4:RRN1297.